Skip to content

Shaperon vs Ventyx Biosciences

Shaperon logo

Shaperon

Delivering the future of IMMUNOLOGY

23 employees · est. 2008 · Seoul, Korea South

VS
Ventyx Biosciences logo

Ventyx Biosciences

242 employees · est. 2018 · San Diego, United States

Shaperon is the older company (2008 vs 2018); Ventyx Biosciences is the larger of the two.

Side-by-Side Comparison

Shaperon Ventyx Biosciences
Founded
2008 older 2018
Headquarters
Seoul, Korea South San Diego, United States
Employees
23 242 larger
Industry
Biopharma, Biotechnology Biopharma, Biotechnology
Funding Stage
Series C Post-IPO Equity
Total Funding
$26.00B $441.60M
Funding Rounds
1 4
Taxonomy
ImmunologyInflammasome InhibitorsClinical Stage BiotechNovel ModalityNanobodiesAnti-viral +9 Clinical Stage ProgramsInflammatory DiseasesAutoimmune DisordersTYK2 InhibitorS1P1 Receptor ModulatorUlcerative Colitis +8
Website
shaperon.com ventyxbio.com
Shaperon logo

About Shaperon

Shaperon is a clinical stage biotech company with a focus on developing novel inflammasome inhibitors (small molecule). Their unique mechanism of action of GPCR-regulated P2X7 inhibition suppresses a broad spectrum of inflammatory cytokines, including IL-1β, IL-18, IL-6, and TNF-α, by controlling bo...

Ventyx Biosciences logo

About Ventyx Biosciences

Ventyx Biosciences is a biotechnology company founded in 2018. It has a diverse portfolio of highly differentiated clinical and pre-clinical stage programs targeting high-value areas. The company's combined assets originate from three separate entities: Oppilan Pharma, focusing on S1P1R; Zomagen Bio...

Also comparing in this category

Comparing more than these two?

Get Shaperon, Ventyx Biosciences and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Shaperon compare?

A PDF of Shaperon and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Shaperon was founded in 2008, based in Seoul, Korea South, with 23 employees. Shaperon is a clinical stage biotech company with a focus on developing novel inflammasome inhibitors (small molecule). Their unique mechanism of action of GPCR-regulated P2X7 inhibition suppresses a. Ventyx Biosciences was founded in 2018, based in San Diego, United States, with 242 employees. Ventyx Biosciences is a biotechnology company founded in 2018. It has a diverse portfolio of highly differentiated clinical and pre-clinical stage programs targeting high-value areas. The company's co.
Shaperon has raised $26.00B and Ventyx Biosciences $441.60M. Latest stage: Shaperon Series C, Ventyx Biosciences Post-IPO Equity.
Both work in Biopharma and Biotechnology and list ulcerative colitis among their focus areas.

Compare Shaperon with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Shaperon on 11 Sep 2024, and Ventyx Biosciences on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout